Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;1(2):191-8.

Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease

Affiliations

Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease

Samantha L Rosenthal et al. Am J Neurodegener Dis. 2012.

Abstract

Late-onset Alzheimer's disease (LOAD) is a complex and multifactorial disease. So far ten loci have been identified for LOAD, including APOE, PICALM, CLU, BIN1, CD2AP, CR1, CD33, EPHA1, ABCA7, and MS4A4A/MS4A6E, but they explain about 50% of the genetic risk and thus additional risk genes need to be identified. Amyloid beta (Aβ) plaques develop in the brains of LOAD patients and are considered to be a pathological hallmark of this disease. Recently 12 new Aβ toxicity modifier genes (ADSSL1, PICALM, SH3KBP1, XRN1, SNX8, PPP2R5C, FBXL2, MAP2K4, SYNJ1, RABGEF1, POMT2, and XPO1) have been identified that potentially play a role in LOAD risk. In this study, we have examined the association of 222 SNPs in these 12 candidate genes with LOAD risk in 1291 LOAD cases and 958 cognitively normal controls. Single site and haplotype analyses were performed using PLINK. Following adjustment for APOE genotype, age, sex, and principal components, we found single nucleotide polymorphisms (SNPs) in PPP2R5C, PICALM, SH3KBP1, XRN1, and SNX8 that showed significant association with risk of LOAD. The top SNP was located in intron 3 of PPP2R5C (P=0.009017), followed by an intron 19 SNP in PICALM (P=0.0102). Haplotype analysis revealed significant associations in ADSSL1, PICALM, PPP2R5C, SNX8, and SH3KBP1 genes. Our data indicate that genetic variation in these new candidate genes affects the risk of LOAD. Further investigation of these genes, including additional replication in other case-control samples and functional studies to elucidate the pathways by which they affect Aβ, are necessary to determine the degree of involvement these genes have for LOAD risk.

Keywords: ADSSL1; FBXL2; Late-onset Alzheimer’s disease (LOAD); MAP2K4; PICALM; POMT2; PPP2R5C; RABGEF1; SH3KBP1; SNPs; SNX8; SYNJ1; XPO1; XRN1; risk genes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Haplotype windows for genes containing significant windows. Lines represent the window tested, with the corresponding SNP rs numbers along the horizontal axis and global p-value on the vertical axis. Significant associations fall above the reference line (dotted) at -log10(0.05)= 1.3.
Figure 2
Figure 2
Haplotype windows for genes containing no significant windows. Lines represent the window tested, with the corresponding SNP rs numbers along the horizontalaxis and global p-value on the vertical axis.

Similar articles

Cited by

References

    1. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10:819–828. - PMC - PubMed
    1. Holtzman DM, Morris JC, Goate AM. Alzheimer’s disease: the challenge of the second century. Sci Transl Med. 2011;3:77sr1. - PMC - PubMed
    1. Hyman BT. Amyloid-dependent and amyloid-independent stages of Alzheimer’s disease. Arch Neurol. 2011;68(8):1062–1064. - PubMed
    1. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Casseli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA. Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: A reference data set. Physiol Genomics. 2008;33:240–256. - PMC - PubMed
    1. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivoby the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s Disease. Nat Med. 1996;2:864–870. - PubMed

LinkOut - more resources